Benzolactam compounds as protein kinase inhibitors
US-2024368136-A1 · Nov 7, 2024 · US
This page is not indexed by search engines while we improve data quality.
Murray Christopher William patents
Murray Christopher William is listed as an inventor on 31 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Murray Christopher William |
| Total patents | 31 |
| First publication | Jan 29, 2015 |
| Latest publication | Nov 7, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Benzolactam compounds as protein kinase inhibitors
US-11939321-B2 · Mar 26, 2024 · US
Benzolactam compounds as protein kinase inhibitors
US-2023019032-A1 · Jan 19, 2023 · US
Pyrazolyl quinoxaline kinase inhibitors
US-2022135544-A1 · May 5, 2022 · US
Benzolactam compounds as protein kinase inhibitors
US-11001575-B1 · May 11, 2021 · US
Pyrazolyl quinoxaline kinase inhibitors
US-2020131153-A1 · Apr 30, 2020 · US
Pyrazolyl quinoxaline kinase inhibitors
US-10519137-B2 · Dec 31, 2019 · US
Benzolactam compounds as protein kinase inhibitors
US-10457669-B2 · Oct 29, 2019 · US
Pteridines as FGFR inhibitors
US-10272087-B2 · Apr 30, 2019 · US
Benzolactam compounds as protein kinase inhibitors
US-2019047990-A1 · Feb 14, 2019 · US
Recent patents
Latest publications not already listed above.
Substituted quinoxalines as FGFR kinase inhibitors
US-10052320-B2 · Aug 21, 2018 · US
Pyrazolyl quinoxaline kinase inhibitors
US-2018127397-A1 · May 10, 2018 · US
Hydroxybenzamide derivatives and their use as inhibitors of HSP90
US-9914719-B2 · Mar 13, 2018 · US
Substituted quinoxalines as FGFR kinase inhibitors
US-9856236-B2 · Jan 2, 2018 · US
Pyrazolyl quinoxaline kinase inhibitors
US-9850228-B2 · Dec 26, 2017 · US
Bicyclic heterocycle compounds and their uses in therapy
US-9617248-B2 · Apr 11, 2017 · US
Bicyclic heterocycle compounds and their uses in therapy
US-9617283-B2 · Apr 11, 2017 · US
Pteridines as fgfr inhibitors
US-2017000796-A1 · Jan 5, 2017 · US
Pyrazolyl quinoxaline kinase inhibitors
US-2016311800-A1 · Oct 27, 2016 · US
Pyrazolyl quinoxaline kinase inhibitors
US-9464071-B2 · Oct 11, 2016 · US
Pteridines as FGFR inhibitors
US-9447098-B2 · Sep 20, 2016 · US
Substitutued quinoxalines as fgfr kinase inhibitors
US-2016220564-A1 · Aug 4, 2016 · US
Substituted quinoxalines as FGFR kinase inhibitors
US-9303029-B2 · Apr 5, 2016 · US
Substituted quinoxalines as FGFR kinase inhibitors
US-9290478-B2 · Mar 22, 2016 · US
Substituted quinoxalines as fgfr kinase inhibitors
US-2016031856-A1 · Feb 4, 2016 · US
Bicyclic heterocycle compounds and their uses in therapy
US-2015353537-A1 · Dec 10, 2015 · US
Pteridines as fgfr inhibitors
US-2015291589-A1 · Oct 15, 2015 · US
Bicyclic heterocycle compounds and their uses in therapy
US-2015259359-A1 · Sep 17, 2015 · US
Pyrazolyl quinoxaline kinase inhibitors
US-2015105368-A1 · Apr 16, 2015 · US
Hydroxybenzamide Derivatives And Their Use As Inhibitors Of HSP90
US-2015045362-A1 · Feb 12, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Astex Therapeutics Ltd | 28 |
| Otsuka Pharma Co Ltd | 6 |
| Saxty Gordon | 1 |
| Murray Christopher William | 1 |
| Berdini Valerio | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 31 |
| C07D403/14 | 29 |
| C07D403/04 | 23 |
| C07D401/14 | 23 |
| C07D413/14 | 22 |